世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
世界の非経口剤形市場レポート、歴史と予測2018-2029年、メーカー別内訳データ、主要地域別、タイプ別、用途別Global Parenteral Dosage Form Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application QYResearch社の調査レポート「非経口投与剤形」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の非経口剤形市場は、2023年から2029年の間に年平均成長率%... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーQYResearch社の調査レポート「非経口投与剤形」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の非経口剤形市場は、2023年から2029年の間に年平均成長率%で、2022年の100万米ドルから増加し、2029年には100万米ドルに達すると予測されています。病院や診療所からの需要が業界の主要な推進力となっている。IQVIA Instituteが発表したGlobal Use of Medicines 2023によると、2022年の世界の薬剤費は約1兆4,800億米ドル（COVIDワクチンと治療関連費を除く）であり、今後数年間は3％〜6％の割合で成長すると予測されている。医薬品支出に関しては、中国のこの数字は2022年には約1660億ドルであった。医薬品への支出は今後数年で増加すると予想される。需要の観点からは、人口の高齢化の傾向、住民の富の増加、健康意識の向上が医薬品需要を牽引する。 Global Use of Medicines 2023によると、米国市場は2022年に正味工場出荷ベースで約629億米ドルを医薬品に費やした。インフレ削減法（IRA）が処方薬価格を引き下げるために640億米ドルを支出し、新しい治療法の採用が今後数年間で増加すると予想されるため、全体的な成長は鈍化する。そのほか、医薬品流通における工場出荷時割引やリベート、特許失効の影響、ジェネリック医薬品やバイオシミラー医薬品の競争も米国医薬品市場に影響を与えるだろう。 レポートの範囲 本レポートは、過去の分析（2018-2022年）と予測計算（2023-2029年）に基づき、読者が世界の非経口剤形市場を多角的に包括的に理解することを目的とし、読者の戦略と意思決定に十分なサポートを提供します。 レポートに掲載されているメーカー、タイプ、用途、地域 企業別 アシュランド テプネル・ファーマ・サービス アセンジア・ファーマシューティカルズ サーモフィッシャーサイエンティフィック プロジェクト・ファーマスーティックス ロンザ BOCサイエンシズ タイプ別セグメント 注射用エマルジョン 注射用粉末 注射用ゲル 用途別セグメント 病院 クリニック その他 地域別セグメント 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア アジア太平洋 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 本レポートの各章は、読者が非経口剤形市場をさらに理解するための詳細な情報を提供します： 第1章：2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品定義、製品タイプ、各タイプの数量および収益分析。 第2章：売上高と収益の比較を含むメーカーの競争状況、非経口投与フォームのメーカーの商業日、各メーカーが提供する製品タイプ、M&A活動、非経口投与フォーム業界で発生した拡張活動。 第3章：北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける非経口投与剤形の過去（2018-2022年）および予測（2023-2029年）の数量および収益分析。 第4章：2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途、各用途の数量および収益分析。 第5章から第9章：北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカの国別レベル分析、数量および収益分析を含む。 第10章：メーカー概要：本社、連絡先、主要事業、非経口投与剤形紹介などの企業の基本情報をカバー。また、各企業の売上高、収益、価格、グロスマージン、最近の動向もこのパートに含まれています。 第11章：原材料、製造コストのような産業チェーンがカバーされています。加えて、市場機会と課題もこの章で強調されている。 第12章：市場チャネル、流通業者と顧客がリストアップされています。 第13章包括的調査に基づくQYResearchの非経口剤形市場の結論。 第14章：QYResearchが採用した方法論とデータソース。 目次1 Parenteral Dosage Form Market Overview1.1 Parenteral Dosage Form Product Overview 1.2 Parenteral Dosage Form Market Segment by Type 1.2.1 Emulsions for Injection 1.2.2 Powders for Injection 1.2.3 Gels for Injection 1.3 Global Parenteral Dosage Form Market Size by Type 1.3.1 Global Parenteral Dosage Form Market Size Overview by Type (2018-2029) 1.3.2 Global Parenteral Dosage Form Historic Market Size Review by Type (2018-2023) 1.3.3 Global Parenteral Dosage Form Forecasted Market Size by Type (2024-2029) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 1.4.2 Europe Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 1.4.3 Asia-Pacific Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 1.4.4 Latin America Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 1.4.5 Middle East and Africa Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 2 Global Parenteral Dosage Form Market Competition by Company 2.1 Global Top Players by Parenteral Dosage Form Sales (2018-2023) 2.2 Global Top Players by Parenteral Dosage Form Revenue (2018-2023) 2.3 Global Top Players by Parenteral Dosage Form Price (2018-2023) 2.4 Global Top Manufacturers Parenteral Dosage Form Manufacturing Base Distribution, Sales Area, Product Type 2.5 Parenteral Dosage Form Market Competitive Situation and Trends 2.5.1 Parenteral Dosage Form Market Concentration Rate (2018-2023) 2.5.2 Global 5 and 10 Largest Manufacturers by Parenteral Dosage Form Sales and Revenue in 2022 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parenteral Dosage Form as of 2022) 2.7 Date of Key Manufacturers Enter into Parenteral Dosage Form Market 2.8 Key Manufacturers Parenteral Dosage Form Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Parenteral Dosage Form Status and Outlook by Region 3.1 Global Parenteral Dosage Form Market Size and CAGR by Region: 2018 VS 2022 VS 2029 3.2 Global Parenteral Dosage Form Historic Market Size by Region 3.2.1 Global Parenteral Dosage Form Sales in Volume by Region (2018-2023) 3.2.2 Global Parenteral Dosage Form Sales in Value by Region (2018-2023) 3.2.3 Global Parenteral Dosage Form Sales (Volume & Value) Price and Gross Margin (2018-2023) 3.3 Global Parenteral Dosage Form Forecasted Market Size by Region 3.3.1 Global Parenteral Dosage Form Sales in Volume by Region (2024-2029) 3.3.2 Global Parenteral Dosage Form Sales in Value by Region (2024-2029) 3.3.3 Global Parenteral Dosage Form Sales (Volume & Value), Price and Gross Margin (2024-2029) 4 Global Parenteral Dosage Form by Application 4.1 Parenteral Dosage Form Market Segment by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Others 4.2 Global Parenteral Dosage Form Market Size by Application 4.2.1 Global Parenteral Dosage Form Market Size Overview by Application (2018-2029) 4.2.2 Global Parenteral Dosage Form Historic Market Size Review by Application (2018-2023) 4.2.3 Global Parenteral Dosage Form Forecasted Market Size by Application (2024-2029) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 4.3.2 Europe Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 4.3.3 Asia-Pacific Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 4.3.4 Latin America Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 4.3.5 Middle East and Africa Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 5 North America Parenteral Dosage Form by Country 5.1 North America Parenteral Dosage Form Historic Market Size by Country 5.1.1 North America Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 5.1.2 North America Parenteral Dosage Form Sales in Volume by Country (2018-2023) 5.1.3 North America Parenteral Dosage Form Sales in Value by Country (2018-2023) 5.2 North America Parenteral Dosage Form Forecasted Market Size by Country 5.2.1 North America Parenteral Dosage Form Sales in Volume by Country (2024-2029) 5.2.2 North America Parenteral Dosage Form Sales in Value by Country (2024-2029) 6 Europe Parenteral Dosage Form by Country 6.1 Europe Parenteral Dosage Form Historic Market Size by Country 6.1.1 Europe Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 6.1.2 Europe Parenteral Dosage Form Sales in Volume by Country (2018-2023) 6.1.3 Europe Parenteral Dosage Form Sales in Value by Country (2018-2023) 6.2 Europe Parenteral Dosage Form Forecasted Market Size by Country 6.2.1 Europe Parenteral Dosage Form Sales in Volume by Country (2024-2029) 6.2.2 Europe Parenteral Dosage Form Sales in Value by Country (2024-2029) 7 Asia-Pacific Parenteral Dosage Form by Region 7.1 Asia-Pacific Parenteral Dosage Form Historic Market Size by Region 7.1.1 Asia-Pacific Parenteral Dosage Form Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 7.1.2 Asia-Pacific Parenteral Dosage Form Sales in Volume by Region (2018-2023) 7.1.3 Asia-Pacific Parenteral Dosage Form Sales in Value by Region (2018-2023) 7.2 Asia-Pacific Parenteral Dosage Form Forecasted Market Size by Region 7.2.1 Asia-Pacific Parenteral Dosage Form Sales in Volume by Region (2024-2029) 7.2.2 Asia-Pacific Parenteral Dosage Form Sales in Value by Region (2024-2029) 8 Latin America Parenteral Dosage Form by Country 8.1 Latin America Parenteral Dosage Form Historic Market Size by Country 8.1.1 Latin America Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 8.1.2 Latin America Parenteral Dosage Form Sales in Volume by Country (2018-2023) 8.1.3 Latin America Parenteral Dosage Form Sales in Value by Country (2018-2023) 8.2 Latin America Parenteral Dosage Form Forecasted Market Size by Country 8.2.1 Latin America Parenteral Dosage Form Sales in Volume by Country (2024-2029) 8.2.2 Latin America Parenteral Dosage Form Sales in Value by Country (2024-2029) 9 Middle East and Africa Parenteral Dosage Form by Country 9.1 Middle East and Africa Parenteral Dosage Form Historic Market Size by Country 9.1.1 Middle East and Africa Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 9.1.2 Middle East and Africa Parenteral Dosage Form Sales in Volume by Country (2018-2023) 9.1.3 Middle East and Africa Parenteral Dosage Form Sales in Value by Country (2018-2023) 9.2 Middle East and Africa Parenteral Dosage Form Forecasted Market Size by Country 9.2.1 Middle East and Africa Parenteral Dosage Form Sales in Volume by Country (2024-2029) 9.2.2 Middle East and Africa Parenteral Dosage Form Sales in Value by Country (2024-2029) 10 Company Profiles 10.1 Ashland 10.1.1 Ashland Company Information 10.1.2 Ashland Introduction and Business Overview 10.1.3 Ashland Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.1.4 Ashland Parenteral Dosage Form Products Offered 10.1.5 Ashland Recent Development 10.2 Tepnel Pharma Services 10.2.1 Tepnel Pharma Services Company Information 10.2.2 Tepnel Pharma Services Introduction and Business Overview 10.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.2.4 Tepnel Pharma Services Parenteral Dosage Form Products Offered 10.2.5 Tepnel Pharma Services Recent Development 10.3 Ascendia Pharmaceuticals 10.3.1 Ascendia Pharmaceuticals Company Information 10.3.2 Ascendia Pharmaceuticals Introduction and Business Overview 10.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Products Offered 10.3.5 Ascendia Pharmaceuticals Recent Development 10.4 Thermo Fisher Scientific 10.4.1 Thermo Fisher Scientific Company Information 10.4.2 Thermo Fisher Scientific Introduction and Business Overview 10.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.4.4 Thermo Fisher Scientific Parenteral Dosage Form Products Offered 10.4.5 Thermo Fisher Scientific Recent Development 10.5 ProJect Pharmaceutics 10.5.1 ProJect Pharmaceutics Company Information 10.5.2 ProJect Pharmaceutics Introduction and Business Overview 10.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.5.4 ProJect Pharmaceutics Parenteral Dosage Form Products Offered 10.5.5 ProJect Pharmaceutics Recent Development 10.6 Lonza 10.6.1 Lonza Company Information 10.6.2 Lonza Introduction and Business Overview 10.6.3 Lonza Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.6.4 Lonza Parenteral Dosage Form Products Offered 10.6.5 Lonza Recent Development 10.7 BOC Sciences 10.7.1 BOC Sciences Company Information 10.7.2 BOC Sciences Introduction and Business Overview 10.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.7.4 BOC Sciences Parenteral Dosage Form Products Offered 10.7.5 BOC Sciences Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Parenteral Dosage Form Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Parenteral Dosage Form Industrial Chain Analysis 11.4 Parenteral Dosage Form Market Dynamics 11.4.1 Parenteral Dosage Form Industry Trends 11.4.2 Parenteral Dosage Form Market Drivers 11.4.3 Parenteral Dosage Form Market Challenges 11.4.4 Parenteral Dosage Form Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Parenteral Dosage Form Distributors 12.3 Parenteral Dosage Form Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer
SummaryParenteral Dosage Form report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Parenteral Dosage Form market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Clinic are the major drivers for the industry. Table of Contents1 Parenteral Dosage Form Market Overview1.1 Parenteral Dosage Form Product Overview 1.2 Parenteral Dosage Form Market Segment by Type 1.2.1 Emulsions for Injection 1.2.2 Powders for Injection 1.2.3 Gels for Injection 1.3 Global Parenteral Dosage Form Market Size by Type 1.3.1 Global Parenteral Dosage Form Market Size Overview by Type (2018-2029) 1.3.2 Global Parenteral Dosage Form Historic Market Size Review by Type (2018-2023) 1.3.3 Global Parenteral Dosage Form Forecasted Market Size by Type (2024-2029) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 1.4.2 Europe Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 1.4.3 Asia-Pacific Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 1.4.4 Latin America Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 1.4.5 Middle East and Africa Parenteral Dosage Form Sales Breakdown by Type (2018-2023) 2 Global Parenteral Dosage Form Market Competition by Company 2.1 Global Top Players by Parenteral Dosage Form Sales (2018-2023) 2.2 Global Top Players by Parenteral Dosage Form Revenue (2018-2023) 2.3 Global Top Players by Parenteral Dosage Form Price (2018-2023) 2.4 Global Top Manufacturers Parenteral Dosage Form Manufacturing Base Distribution, Sales Area, Product Type 2.5 Parenteral Dosage Form Market Competitive Situation and Trends 2.5.1 Parenteral Dosage Form Market Concentration Rate (2018-2023) 2.5.2 Global 5 and 10 Largest Manufacturers by Parenteral Dosage Form Sales and Revenue in 2022 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parenteral Dosage Form as of 2022) 2.7 Date of Key Manufacturers Enter into Parenteral Dosage Form Market 2.8 Key Manufacturers Parenteral Dosage Form Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Parenteral Dosage Form Status and Outlook by Region 3.1 Global Parenteral Dosage Form Market Size and CAGR by Region: 2018 VS 2022 VS 2029 3.2 Global Parenteral Dosage Form Historic Market Size by Region 3.2.1 Global Parenteral Dosage Form Sales in Volume by Region (2018-2023) 3.2.2 Global Parenteral Dosage Form Sales in Value by Region (2018-2023) 3.2.3 Global Parenteral Dosage Form Sales (Volume & Value) Price and Gross Margin (2018-2023) 3.3 Global Parenteral Dosage Form Forecasted Market Size by Region 3.3.1 Global Parenteral Dosage Form Sales in Volume by Region (2024-2029) 3.3.2 Global Parenteral Dosage Form Sales in Value by Region (2024-2029) 3.3.3 Global Parenteral Dosage Form Sales (Volume & Value), Price and Gross Margin (2024-2029) 4 Global Parenteral Dosage Form by Application 4.1 Parenteral Dosage Form Market Segment by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Others 4.2 Global Parenteral Dosage Form Market Size by Application 4.2.1 Global Parenteral Dosage Form Market Size Overview by Application (2018-2029) 4.2.2 Global Parenteral Dosage Form Historic Market Size Review by Application (2018-2023) 4.2.3 Global Parenteral Dosage Form Forecasted Market Size by Application (2024-2029) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 4.3.2 Europe Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 4.3.3 Asia-Pacific Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 4.3.4 Latin America Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 4.3.5 Middle East and Africa Parenteral Dosage Form Sales Breakdown by Application (2018-2023) 5 North America Parenteral Dosage Form by Country 5.1 North America Parenteral Dosage Form Historic Market Size by Country 5.1.1 North America Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 5.1.2 North America Parenteral Dosage Form Sales in Volume by Country (2018-2023) 5.1.3 North America Parenteral Dosage Form Sales in Value by Country (2018-2023) 5.2 North America Parenteral Dosage Form Forecasted Market Size by Country 5.2.1 North America Parenteral Dosage Form Sales in Volume by Country (2024-2029) 5.2.2 North America Parenteral Dosage Form Sales in Value by Country (2024-2029) 6 Europe Parenteral Dosage Form by Country 6.1 Europe Parenteral Dosage Form Historic Market Size by Country 6.1.1 Europe Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 6.1.2 Europe Parenteral Dosage Form Sales in Volume by Country (2018-2023) 6.1.3 Europe Parenteral Dosage Form Sales in Value by Country (2018-2023) 6.2 Europe Parenteral Dosage Form Forecasted Market Size by Country 6.2.1 Europe Parenteral Dosage Form Sales in Volume by Country (2024-2029) 6.2.2 Europe Parenteral Dosage Form Sales in Value by Country (2024-2029) 7 Asia-Pacific Parenteral Dosage Form by Region 7.1 Asia-Pacific Parenteral Dosage Form Historic Market Size by Region 7.1.1 Asia-Pacific Parenteral Dosage Form Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 7.1.2 Asia-Pacific Parenteral Dosage Form Sales in Volume by Region (2018-2023) 7.1.3 Asia-Pacific Parenteral Dosage Form Sales in Value by Region (2018-2023) 7.2 Asia-Pacific Parenteral Dosage Form Forecasted Market Size by Region 7.2.1 Asia-Pacific Parenteral Dosage Form Sales in Volume by Region (2024-2029) 7.2.2 Asia-Pacific Parenteral Dosage Form Sales in Value by Region (2024-2029) 8 Latin America Parenteral Dosage Form by Country 8.1 Latin America Parenteral Dosage Form Historic Market Size by Country 8.1.1 Latin America Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 8.1.2 Latin America Parenteral Dosage Form Sales in Volume by Country (2018-2023) 8.1.3 Latin America Parenteral Dosage Form Sales in Value by Country (2018-2023) 8.2 Latin America Parenteral Dosage Form Forecasted Market Size by Country 8.2.1 Latin America Parenteral Dosage Form Sales in Volume by Country (2024-2029) 8.2.2 Latin America Parenteral Dosage Form Sales in Value by Country (2024-2029) 9 Middle East and Africa Parenteral Dosage Form by Country 9.1 Middle East and Africa Parenteral Dosage Form Historic Market Size by Country 9.1.1 Middle East and Africa Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 9.1.2 Middle East and Africa Parenteral Dosage Form Sales in Volume by Country (2018-2023) 9.1.3 Middle East and Africa Parenteral Dosage Form Sales in Value by Country (2018-2023) 9.2 Middle East and Africa Parenteral Dosage Form Forecasted Market Size by Country 9.2.1 Middle East and Africa Parenteral Dosage Form Sales in Volume by Country (2024-2029) 9.2.2 Middle East and Africa Parenteral Dosage Form Sales in Value by Country (2024-2029) 10 Company Profiles 10.1 Ashland 10.1.1 Ashland Company Information 10.1.2 Ashland Introduction and Business Overview 10.1.3 Ashland Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.1.4 Ashland Parenteral Dosage Form Products Offered 10.1.5 Ashland Recent Development 10.2 Tepnel Pharma Services 10.2.1 Tepnel Pharma Services Company Information 10.2.2 Tepnel Pharma Services Introduction and Business Overview 10.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.2.4 Tepnel Pharma Services Parenteral Dosage Form Products Offered 10.2.5 Tepnel Pharma Services Recent Development 10.3 Ascendia Pharmaceuticals 10.3.1 Ascendia Pharmaceuticals Company Information 10.3.2 Ascendia Pharmaceuticals Introduction and Business Overview 10.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Products Offered 10.3.5 Ascendia Pharmaceuticals Recent Development 10.4 Thermo Fisher Scientific 10.4.1 Thermo Fisher Scientific Company Information 10.4.2 Thermo Fisher Scientific Introduction and Business Overview 10.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.4.4 Thermo Fisher Scientific Parenteral Dosage Form Products Offered 10.4.5 Thermo Fisher Scientific Recent Development 10.5 ProJect Pharmaceutics 10.5.1 ProJect Pharmaceutics Company Information 10.5.2 ProJect Pharmaceutics Introduction and Business Overview 10.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.5.4 ProJect Pharmaceutics Parenteral Dosage Form Products Offered 10.5.5 ProJect Pharmaceutics Recent Development 10.6 Lonza 10.6.1 Lonza Company Information 10.6.2 Lonza Introduction and Business Overview 10.6.3 Lonza Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.6.4 Lonza Parenteral Dosage Form Products Offered 10.6.5 Lonza Recent Development 10.7 BOC Sciences 10.7.1 BOC Sciences Company Information 10.7.2 BOC Sciences Introduction and Business Overview 10.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023) 10.7.4 BOC Sciences Parenteral Dosage Form Products Offered 10.7.5 BOC Sciences Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Parenteral Dosage Form Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Parenteral Dosage Form Industrial Chain Analysis 11.4 Parenteral Dosage Form Market Dynamics 11.4.1 Parenteral Dosage Form Industry Trends 11.4.2 Parenteral Dosage Form Market Drivers 11.4.3 Parenteral Dosage Form Market Challenges 11.4.4 Parenteral Dosage Form Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Parenteral Dosage Form Distributors 12.3 Parenteral Dosage Form Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD（breakdown data）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
